Do mental health websites improve help-seeking in adolescents?

shutterstock_94844608

Maxine Howard summarises the findings of a recent review of online mental health services for young people, which finds little evidence to suggest that websites increase help-seeking in adolescents.

[read the full story...]

Long duration of untreated psychosis is associated with a range of poor outcomes

shutterstock_111899612

Joe Judge appraises a recent systematic review and meta-analysis looking at the duration of untreated psychosis as a predictor of long-term outcomes in schizophrenia.

[read the full story...]

Smoking cessation in the emergency setting

shutterstock_198435872

Olivia Maynard summarises a systematic review of smoking cessation interventions in the emergency setting, which highlights the poor quality and heterogenous nature of the published trials in this field.

[read the full story...]

Antidepressants for depression in pregnancy: new systematic review says the jury’s still out

Nikki Newhouse summarises a recent US health technology assessment of antidepressants for depression in pregnancy and the postpartum period, which concludes that the evidence remains inconclusive about the benefits and harms of antidepressants for depression in pregnancy.

[read the full story...]

Tricyclic antidepressants for ADHD in children and adolescents: Cochrane review finds no evidence to support prescribing

shutterstock_147565085

Helge Hasselman summarises a Cochrane review of tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents, which finds low quality evidence and no justification for prescribing these drugs in this group of patients.

[read the full story...]

Reducing benzodiazepine prescribing in primary care

shutterstock_69687928

Liz Hughes summarises two recent studies (1 systematic review and 1 RCT) that both investigate brief interventions for reducing the use of benzodiazepines in primary care.

[read the full story...]

Efficacy of high vs. low-potency first-generation antipsychotics for schizophrenia

Screen Shot 2014-10-03 at 13.24.52

Laurence Palfreyman summarises 3 recent Cochrane reviews, which investigate high-potency versus low-potency first-generation antipsychotic drugs for schizophrenia. The reviews find little difference in efficacy between the high-potency antipsychotics Trifluoperazine, Haloperidol, Fluphenazine, and low-potency typical antipsychotics.

[read the full story...]

Lost in anxiety: treatment-resistant anxiety in older people

shutterstock_219436936

Andrés Fonseca appraises a new systematic review of interventions for treatment-resistant anxiety in older people, which finds a disconcerting lack of evidence to help him support the many older patients he sees who are affected by anxiety disorders.

[read the full story...]

Are treatments for bipolar disorder cost-effective?

shutterstock_177676103

Chris Sampson reports on a recent systematic review and critical appraisal of economic evaluations in bipolar disorder. He finds that there’s a pressing need for new studies, especially discrete event simulations.

[read the full story...]

Cytisine and varenicline for smoking cessation

shutterstock_125942273

Andrew Jones and Chris Sampson report on a systematic review and economic evaluation of cytisine and varenicline for smoking cessation, which finds that both drugs are clinically effective compared with placebo.

[read the full story...]